S

SMO Clinplus Co Ltd
SZSE:301257

Watchlist Manager
SMO Clinplus Co Ltd
SZSE:301257
Watchlist
Price: 65.31 CNY -6.42% Market Closed
Market Cap: 5.2B CNY

Wall Street
Price Targets

Price Targets Summary
SMO Clinplus Co Ltd

There are no price targets for SMO Clinplus Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
SMO Clinplus Co Ltd Competitors:
Price Targets
CTKB
Cytek Biosciences Inc
9% Upside
CHEMM
Chemometec A/S
23% Upside
RVU
Ryvu Therapeutics SA
100% Upside
PPGN
PolyPeptide Group AG
24% Upside
SAILIFE
Sai Life Sciences Ltd
29% Upside
INNOVACAP
Innova Captab Ltd
22% Upside
ICLR
ICON PLC
14% Upside
1521
Frontage Holdings Corp
17% Upside

Revenue
Forecast

Revenue Estimate
SMO Clinplus Co Ltd

For the last 4 years the compound annual growth rate for SMO Clinplus Co Ltd's revenue is 24%. The projected CAGR for the next 3 years is 8%.

24%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
SMO Clinplus Co Ltd

For the last 4 years the compound annual growth rate for SMO Clinplus Co Ltd's operating income is 25%. The projected CAGR for the next 1 year is 185%.

25%
Past Growth
185%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
SMO Clinplus Co Ltd

For the last 4 years the compound annual growth rate for SMO Clinplus Co Ltd's net income is 32%. The projected CAGR for the next 3 years is 11%.

32%
Past Growth
11%
Estimated Growth
Estimates Accuracy
1%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SMO Clinplus Co Ltd's stock price target?
Not Available

SMO Clinplus Co Ltd doesn't have any price targets made by Wall Street professionals.

What is SMO Clinplus Co Ltd's Revenue forecast?
Projected CAGR
8%

For the last 4 years the compound annual growth rate for SMO Clinplus Co Ltd's revenue is 24%. The projected CAGR for the next 3 years is 8%.

What is SMO Clinplus Co Ltd's Operating Income forecast?
Projected CAGR
185%

For the last 4 years the compound annual growth rate for SMO Clinplus Co Ltd's operating income is 25%. The projected CAGR for the next 1 year is 185%.

What is SMO Clinplus Co Ltd's Net Income forecast?
Projected CAGR
11%

For the last 4 years the compound annual growth rate for SMO Clinplus Co Ltd's net income is 32%. The projected CAGR for the next 3 years is 11%.

Back to Top